U.S. Biotech Stock News

Cybin’s subsidiary Helus Pharma recently saw Executive Chairman and Co‑founder Eric So re‑assume the role of Interim CEO after the board requested Michael Cola’s departure, while also adding neuroscience veteran Dr. Ken Kramer as Senior Vice President of Medical Affairs. This combination of a board-driven leadership change and a high-profile medical affairs hire could influence how investors assess Helus’ execution capabilities within Cybin’s broader clinical platform. We’ll now examine how...

Wondering if NextEra Energy's current share price lines up with its underlying value, or if the recent run means you are late to the story? The stock last closed at US$90.00, with returns of 11.2% year to date and 37.8% over the past year, even though the 7-day and 30-day returns were 1.4% and 0.3% declines. Recent coverage has focused on NextEra Energy's role as a major US utilities player and how its scale and asset base position it within the sector. This context is important when...

Earlier this week, Boyd Gaming Corporation reported its first-quarter 2026 results, after investors had closely watched expectations for flat year-on-year revenue and the balance between resilient core customer play and softer destination demand. The company’s ongoing capital projects, including the Cadence Crossing opening and Sky River expansion, are now under scrutiny for how meaningfully they can offset pressure on hotel and resort-driven margins. We’ll now examine how management’s...

Fortinet (FTNT) stock is back in focus after the company received Google Cloud’s 2026 Partner of the Year Award for Workload Security, spotlighting its FortiCNAPP platform for hybrid and multi cloud protection. See our latest analysis for Fortinet. The recent Google Cloud award has arrived during a period of strong near term momentum, with Fortinet’s share price at US$87.09 after a 9.35% 7 day share price return. However, the 1 year total shareholder return is a 10.22% decline, while the 5...

Q4 earnings spark sharp move in Braze stock Braze (BRZE) recently reported Q4 earnings, with revenue up 27.9% year on year. The company beat analyst expectations on revenue, billings, and EBITDA, and the stock has climbed 25.8% since the announcement. See our latest analysis for Braze. The strong Q4 reaction comes after a mixed year, with a 27.1% 30 day share price return and a 26.1% decline year to date, while the 1 year total shareholder return is down 15.1%. Recent momentum is therefore...

Warner Music Group (NasdaqGS:WMG) has entered a landmark partnership with TuStreams in the Música Mexicana genre. The deal includes a minority investment by Warner Music Group and a global distribution agreement for TuStreams' catalog and future releases. The partnership is designed to broaden Warner Music Group's reach in Música Mexicana and connect TuStreams artists with international audiences. For investors tracking Warner Music Group at a share price of $29.31, this move comes...

Krystal Biotech (KRYS) has drawn fresh attention after recent share price moves, with the stock showing a mix of gains over the past month and year and some softness over the past 3 months. See our latest analysis for Krystal Biotech. The recent 10.34% 1 month share price return alongside an 11.76% year to date share price gain contrasts with a softer 4.56% 3 month share price return. At the same time, the 66.43% 1 year total shareholder return points to momentum that has been building over a...

What Carter's Stock Performance Suggests Right Now Carter's (CRI) has drawn fresh attention after recent trading left shares around $38.87, with the stock showing mixed returns over the past week, month, and past 3 months that may prompt closer portfolio review. See our latest analysis for Carter's. The recent 7.3% 7 day share price return and 12.8% 30 day share price return sit against a 17.1% year to date share price gain. However, the 5 year total shareholder return of a 54.5% decline...

Freshpet’s latest earnings shift focus to growth quality and cash generation Freshpet (FRPT) recently reported quarterly results that included surpassing US$1b in net sales for the first time, beating analysts’ adjusted operating income estimates, and reporting positive free cash flow. Management also highlighted expanded margins alongside these results. The share price has pulled back since the report, giving investors a fresh set of financial markers to weigh against Freshpet’s longer term...

The Trade Desk recently announced it will release its first-quarter 2026 results on May 7, alongside a webcast and call, while investor attention has intensified after CEO Jeff Green purchased US$150,000,000 of company shares and the firm highlighted continued adoption of its AI-driven advertising tools. These developments come as analysts debate the impact of growing competition, platform fee scrutiny, and evolving programmatic ad trends on The Trade Desk’s longer-term earnings potential...

Earlier this week, Exelixis drew attention after a report said a rival’s triple‑drug kidney cancer regimen failed in a Dow Jones pharma update, highlighting Exelixis as a key competitor in this treatment area. This setback for a competing approach subtly improves the perceived competitive position of Exelixis’s kidney cancer franchise at a time when oncology differentiation is critical. We’ll now explore how a rival’s failed kidney cancer regimen may influence Exelixis’s existing oncology...

Investors may be wondering if Kosmos Energy's current share price still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$2.85, with returns of 10.5% over 7 days, 5.9% over 30 days, 219.2% year to date and 63.8% over 1 year. The 3 year and 5 year returns stand at a 53.6% decline and a 2.4% decline respectively. Recent coverage around Kosmos Energy has focused on its position in the energy sector and how investors are reassessing risk and...

Interparfums stock: recent performance snapshot Interparfums (IPAR) has drawn fresh attention after recent share price swings, with the stock down 3.4% over the past day and 2.1% over the past week, while month performance stands modestly positive. See our latest analysis for Interparfums. At a share price of US$91.96, Interparfums shows short term share price pressure with a 1 day share price return decline of 3.4% and a 1 year total shareholder return decline of 11.9%, pointing to fading...

Wondering if PPL at around US$37.78 is giving you value or just price noise? This article walks through what that price tag might really mean for you. The stock has seen a 4.0% decline over the last 7 days, while returns sit at 2.4% over 30 days, 7.6% year to date and 7.6% over 1 year, with longer term returns of 47.6% over 3 years and 56.8% over 5 years, which shows how the story has evolved over time. Recent coverage of PPL has focused on its role in the US utilities sector and how...

Analyst sentiment around Bunge Global (BG) has turned more favorable ahead of its upcoming earnings, as consensus forecasts for quarterly earnings per share have been revised higher, and the company also carries a positive Earnings ESP. See our latest analysis for Bunge Global. At a share price of $125.77, Bunge Global has seen momentum build, with a 7 day share price return of 4.81% and a year to date share price return of 35.76%, while the 1 year total shareholder return of 62.43% points to...

Recent performance snapshot Biohaven (BHVN) has recently caught investor attention after a one-month return of 22.2%, contrasting with a past three-month total return decline of 22.4% and a one-year total return decline of 50.1%. See our latest analysis for Biohaven. The recent 22.2% one month share price return, alongside a 4.8% one day gain at a share price of US$10.68, contrasts with a 50.1% one year total shareholder return decline. This suggests short term momentum after a tougher period...

In April 2026, Intel drew fresh investor attention as analysts highlighted accelerating demand for its server CPUs tied to AI infrastructure, alongside new partnerships such as Google’s AI and cloud collaboration and Tesla’s plan to use Intel’s upcoming 14A process at its Terafab chip project. This combination of analyst optimism, high-profile cloud and automotive customers, and a growing role for Intel’s foundry ambitions is reshaping how investors view the company’s place in the AI...

Wondering whether Advanced Micro Devices at US$303.46 still offers value after its strong run? This article breaks down what the current price might be implying about the stock. The share price performance has been strong, with returns of 17.6% over 7 days, 49.7% over 30 days, 35.8% year to date, 235.7% over 1 year, 253.1% over 3 years, and 261.2% over 5 years. Recent market attention on Advanced Micro Devices has focused on its role in high performance computing and semiconductors, with...

Wondering if DoorDash at around US$182 per share is priced for its future or already reflecting a lot of optimism? This article focuses squarely on what the current valuation is really telling you. The stock has returned 1.3% over the last 7 days and 13.9% over the last 30 days, while the year to date return stands at a 17.1% decline and the 1 year return is 0.6% with a very large 3 year return figure. Recent coverage has centered on DoorDash as one of the larger listed food delivery...

Wondering whether Carnival Corporation & at around US$26.94 is a bargain or already pricing in the recovery story? This breakdown will walk through what that price really implies about the stock's value. The share price has been volatile recently, with a 6.5% decline over the last 7 days, a 5.9% gain over 30 days, a 12.9% decline year to date, a 46.5% return over the past year, a very large 3 year return, and a 2.6% decline over 5 years. Recent headlines around Carnival Corporation & have...

Meritage Homes (NYSE:MTH) reported a significant year over year decline in Q1 2026 revenue and net earnings. Management cited a severe winter storm and geopolitical tensions affecting consumer sentiment and mortgage rates as key pressures. The company maintained a strong balance sheet while completing share repurchases and paying dividends during the quarter. Meritage Homes also expanded its community count despite the operational headwinds in Q1 2026. Meritage Homes, a major US...

Generac Holdings recently entered the spotlight ahead of its late-April 2026 earnings release, with analysts expecting year-over-year growth in both earnings and revenue for the March quarter. The gap between the Most Accurate Estimate and the Zacks Consensus Estimate highlights a recent upswing in analyst optimism about Generac’s earnings outlook. With analysts increasingly optimistic about Generac’s upcoming earnings, we’ll examine how this upgraded profit outlook affects the company’s...

XPeng recently unveiled its next-generation "Physical AI" ecosystem at the Beijing Auto Show, showcasing its VLA 2.0 intelligent driving system, robotics efforts, and aerial mobility concepts as Physical AI enters mass production in 2026. This marks a shift in XPeng’s positioning from a pure smart EV maker toward a broader physical AI platform spanning cars, robots, and flying vehicles, which could broaden how the company is perceived by consumers and partners. We’ll now explore how XPeng’s...

Resideo Technologies: Event Driven Stock Check In Resideo Technologies (REZI) has caught investor attention after a recent move in its share price, with the stock closing at $40.57 and showing double digit total returns over the past year and past 3 months. See our latest analysis for Resideo Technologies. The recent 16.9% 1 month share price return and 15.4% year to date share price return sit alongside a very strong 1 year total shareholder return of 163.1% and 3 year total shareholder...